Ptc Therapeutics (PTCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 54,106 | 58,321 | 50,286 | 35,658 | 40,165 |
| Marketable Securities | 148,471 | 173,345 | 198,052 | 237,235 | 258,547 |
| Receivables | 32,173 | 24,929 | 27,409 | 19,765 | 22,618 |
| Inventories | 1,354 | N/A | N/A | N/A | N/A |
| TOTAL | $240,727 | $261,286 | $280,607 | $297,434 | $326,434 |
| Non-Current Assets | |||||
| PPE Net | 7,059 | 7,429 | 7,059 | 7,601 | 8,426 |
| Other Non-Current Assets | 859 | 630 | 511 | 528 | 372 |
| TOTAL | $7,918 | $8,059 | $7,570 | $8,129 | $8,798 |
| Total Assets | $248,645 | $269,345 | $288,177 | $305,563 | $335,232 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 257 | N/A | N/A |
| Accounts payable and accrued liabilities | 45,153 | 48,759 | 47,759 | 42,183 | 43,493 |
| Other current liabilities | 265 | 865 | N/A | N/A | N/A |
| TOTAL | $45,418 | $49,624 | $48,926 | $42,909 | $43,889 |
| Non-Current Liabilities | |||||
| Long Term Debt | 99,895 | 98,216 | 96,559 | 94,936 | 93,366 |
| Deferred Revenues | N/A | N/A | 910 | 726 | 396 |
| Other Non-Current Liabilities | 311 | 335 | 2,515 | 2,094 | 1,976 |
| TOTAL | $102,400 | $100,138 | $99,074 | $97,030 | $95,342 |
| Total Liabilities | $147,818 | $149,762 | $148,000 | $139,939 | $139,231 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 41,244 | 34,556 | 34,318 | 34,248 | 34,265 |
| Common Shares | 34 | 34 | 34 | 34 | 34 |
| Retained earnings | -764,165 | -735,108 | -708,313 | -673,145 | -634,231 |
| Other shareholders' equity | -876 | -1,485 | 756 | 885 | 1,084 |
| TOTAL | $100,827 | $119,583 | $140,177 | $165,624 | $196,001 |
| Total Liabilities And Equity | $248,645 | $269,345 | $288,177 | $305,563 | $335,232 |